✦ LIBER ✦

Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer

✍ Scribed by Dapeng Ding, Ying Zhang, Xiaofeng He, Wei Meng, Wenli Ma, Wenling Zheng

Book ID: 118726885
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 80 KB
Volume: 14
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr3159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

German populations with infrequent CHEK2

German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer

✍ Muhammad U. Rashid; Anna Jakubowska; Christina Justenhoven; Volker Harth; Beate 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Breast Cancer Survival and Tumor Charact

Breast Cancer Survival and Tumor Characteristics in Premenopausal Women Carrying the CHEK2*1100delC Germline Mutation

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

The CHEK2 1100delC Mutation Identifies F

The CHEK2 1100delC Mutation Identifies Families with a Hereditary Breast and Colorectal Cancer Phenotype

✍ Hanne Meijers-Heijboer; Marijke Wasielewski; Anja Wagner; Antoinette Hollestelle 📂 Article 📅 2003 🏛 American Society of Human Genetics 🌐 English ⚖ 957 KB

Correlation of CHEK2 protein expression

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

✍ Outi Kilpivaara; Jirina Bartkova; Hannaleena Eerola; Kirsi Syrjäkoski; Pia Vahte 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 145 KB

The CHEK2 kinase is a tumor suppressor whose activation in response to DNA double-strand breaks contributes to cell cycle arrest or apoptosis. The c.1100delC mutation is associated with familial breast cancer, and tumors from mutation carriers show reduced or absent CHEK2 protein expression. We have

CHEK2*1100delC Heterozygosity in Women W

CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer

✍ Wu, X.; Zhao, H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

P7 The CHEK2 1100delC mutation is not pr

P7 The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation

✍ D.H. Choi; H.Y. Cho; M.H. Lee; H.S. Park; S.H. Ahn; B.G. Haffty 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB